These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 26948348)

  • 41. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
    Tykocki T; Michalik R; Bonicki W; Nauman P
    Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale for Aggressive Resection and General Surgical Principles for Intracranial Gliomas.
    McCutcheon IE; Chernov MF
    Prog Neurol Surg; 2018; 30():63-105. PubMed ID: 29241170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Supraorbital trans-eyebrow craniotomy and fluorescence-guided resection of fronto-basal high grade gliomas.
    Prat-Acín R; Galeano-Senabre I; Pancucci G; Evangelista R; Ayuso-Sacido A; Botella C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1586-90. PubMed ID: 23453153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgery for gliomas.
    Whittle IR
    Curr Opin Neurol; 2002 Dec; 15(6):663-9. PubMed ID: 12447103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A low-field intraoperative MRI system for glioma surgery: is it worthwhile?
    Oh DS; Black PM
    Neurosurg Clin N Am; 2005 Jan; 16(1):135-41. PubMed ID: 15561533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical management of low-grade gliomas.
    Gerard CS; Straus D; Byrne RW
    Semin Oncol; 2014 Aug; 41(4):458-467. PubMed ID: 25173139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of intraoperative ultra low-field magnetic resonance imaging in glioma surgery.
    Senft C; Seifert V; Hermann E; Franz K; Gasser T
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):257-66; discussion 266-7. PubMed ID: 18981831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical Management of Gliomas in Eloquent Cortex.
    Ferguson SD; McCutcheon IE
    Prog Neurol Surg; 2018; 30():159-172. PubMed ID: 29241173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical oncology for gliomas: the state of the art.
    Sanai N; Berger MS
    Nat Rev Clin Oncol; 2018 Feb; 15(2):112-125. PubMed ID: 29158591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship of intraoperative ultrasound characteristics with pathological grades and Ki-67 proliferation index in intracranial gliomas.
    Baskan O; Silav G; Sari R; Canoz O; Elmaci I
    J Med Ultrason (2001); 2015 Apr; 42(2):231-7. PubMed ID: 26576577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New development of surgical treatment for malignant brain tumors].
    Sonoda Y; Kamaya T
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):437-41. PubMed ID: 15853206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resecting diffuse low-grade gliomas to the boundaries of brain functions: a new concept in surgical neuro-oncology.
    Duffau H
    J Neurosurg Sci; 2015 Dec; 59(4):361-71. PubMed ID: 25907410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical management of intracranial gliomas.
    Simon M; Schramm J
    Recent Results Cancer Res; 2009; 171():105-24. PubMed ID: 19322540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Supratotal resection of diffuse gliomas - an overview of its multifaceted implications.
    Yordanova YN; Duffau H
    Neurochirurgie; 2017 Jun; 63(3):243-249. PubMed ID: 28185647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical strategy for insular glioma.
    Przybylowski CJ; Hervey-Jumper SL; Sanai N
    J Neurooncol; 2021 Feb; 151(3):491-497. PubMed ID: 33611715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in the Surgical Management of Low-Grade Glioma.
    Hollon T; Hervey-Jumper SL; Sagher O; Orringer DA
    Semin Radiat Oncol; 2015 Jul; 25(3):181-8. PubMed ID: 26050588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
    Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
    Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multimodality Imaging Techniques to Assist Surgery in Low-Grade Gliomas.
    Mazzucchi E; La Rocca G; Ius T; Sabatino G; Della Pepa GM
    World Neurosurg; 2020 Jan; 133():423-425. PubMed ID: 31881559
    [No Abstract]   [Full Text] [Related]  

  • 60. Combining Functional Studies with Intraoperative MRI in Glioma Surgery.
    Krivosheya D; Prabhu SS
    Neurosurg Clin N Am; 2017 Oct; 28(4):487-497. PubMed ID: 28917278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.